🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase III multi-centre study in three periods: the first period i...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00416520
Vascular calcification and endothelial dysfunction (ED) contribute to the d...
Status
Completed
Location
Gulhane School of Medicine
Start Date
2008-01
Trial ID
NCT01135615
Treatments Being Tested
Approximately 207 hyperphosphatemic CKD patients not on dialysis will be en...
Status
Terminated
Location
Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie und Hämodialyse
Start Date
2009-01
Trial ID
NCT00833768
Treatments Being Tested
Fibroblast Growth Factor 23 (FGF23) is a molecule that has been implicated ...
Status
Completed
Location
Penn State Milton S. Hershey Medical Center
Start Date
2011-03
Trial ID
NCT01308242
Treatments Being Tested
FGF-23 is a newly described protein that is an important regulator of phosp...
Status
Completed
Location
UCLA
Start Date
2009-10
Trial ID
NCT00999037
Treatments Being Tested
This is a Phase 3, Open-label, Randomised, Active-controlled, Parallel Grou...
Status
Terminated
Location
University of Alabama at Birmingham School of Medicine
Start Date
2016-05-26
Trial ID
NCT02688764
Treatments Being Tested
The purpose of this clinical study is to compare the effects of Genz-644470...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00853242
Treatments Being Tested
This study will evaluate the efficacy of SBR759 compared to sevelamer HCl i...
Status
Completed
Location
Novartis
Start Date
2008-07
Trial ID
NCT00704483
Treatments Being Tested
The purpose of this study is to determine if subjects on 2g AMG 223 will ac...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00756860
Treatments Being Tested
This is a Phase 3, randomised, active controlled, multicentre extension stu...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01464190
Treatments Being Tested